Apotheek Dochy SRL
Apotheek Dochy reported total assets of 594,954 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jul 2026).
The score of Apotheek Dochy shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +48 % Total assets -11 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Dochy's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 17,348 € | ||||
| Equity | 144,979 € | ||||
| Cash | 65,346 € | ||||
| EBITDA | 55,840 € | ||||
| Total assets | 594,954 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 23 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Apotheek Dochy's financial analysis
- Solvency24.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Dochy
Apotheek Dochy's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0847.709.130
- VAT number
- BE0847709130
- Peppol
- Registered · 0208:0847709130 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Jul 2012
- Registered office
- 8610 Kortemark
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Dochy (SRL) has been based in Kortemark since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 17,348 € and equity of 144,979 €; its revenue is not published. Its solvency stands at 24.4%, below the median of its sector (44.2%).
Companies similar to Apotheek Dochy
Companies in the same business, of comparable size and area, outside its group.
- ThePharm Retail sale of pharmaceutical products Antwerp · balance sheet 593,897 €
- Pharmacie Detroz Retail sale of pharmaceutical products Ramillies · balance sheet 596,947 €
- Stella and Maynard Retail sale of pharmaceutical products Ghent · balance sheet 597,024 €
- LO-Pharma Retail sale of pharmaceutical products Lubbeek · balance sheet 597,566 €
- Jacky-Mo Retail sale of pharmaceutical products Schaerbeek · balance sheet 597,743 €
- Hercomex Retail sale of pharmaceutical products Jurbise · balance sheet 591,927 €
- Centrumapotheek Torhout Retail sale of pharmaceutical products Torhout · balance sheet 591,095 €
- Meys-Gauchier Retail sale of pharmaceutical products Sint-Pieters-Leeuw · balance sheet 591,047 €
Frequently asked questions about Apotheek Dochy
What is the revenue of Apotheek Dochy?
Apotheek Dochy files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Dochy?
In Belgium, the VAT number is the company number prefixed with BE: BE0847709130 for Apotheek Dochy, if the company is VAT-registered. Its company number (CBE) is 0847.709.130.
Where is the registered office of Apotheek Dochy?
According to the CBE register, the registered office of Apotheek Dochy is in 8610 Kortemark.
What is the equity of Apotheek Dochy?
At the close of the 2025 financial year, the equity of Apotheek Dochy amounts to 144,979 €, a solvency of 24.4% of total assets.
Who manages Apotheek Dochy?
The register lists 1 active mandates at Apotheek Dochy. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Dochy
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →